Covid Medicines Delivery Service




The COVID Medicines Delivery Unit (CMDU) provides new COVID-19 treatments for patients at the highest risk in the community with the aim of reducing deterioration and preventing hospitalisation. 

Haringey GP Federation and Islington GP Federation are joint service providers for any eligible patients residing in North Central London (Barnet, Camden, Enfield, Haringey and Islington).

image depicting an woman holding medication


What does treatment involve?

Treatments involve medicines which stop the virus that causes COVID-19 from making copies of itself in the body. They are given to high-risk patients with a positive PCR or lateral flow test within five days of symptoms onset. The purpose of treatment is to reduce the risk of deterioration due to COVID19 and prevent hospitalisation for high-risk patients.  

Upon receipt of referral, a prescribing pharmacist screens the patients' GP medical record for eligibility and determines a suitable treatment option. The pharmacist then calls the patient to assess the severity of symptoms and proceed with treatment provision if appropriate.


Pregnant Patient with Covid

Patients can access the service via:

Self-referral by calling: 020 3838 7121 or emailing 


Opening hours:

10:00am to 1:30pm Monday to Friday and 10am to 12noon Saturday and Sunday. During these hours please leave a voicemail, and messages will be responded to within 24 hours.

Email at (monitored 9am to 5pm Monday to Friday and 9:00am to 2:00pm Saturday and Sunday).


Who is eligible for treatment?

The service is available for all high-risk patients, including children over 12 as defined by the Gov.Uk independent advisory group.

More information about eligibility can be found here


Other FAQs

What happens if someone is visiting or has temporary accommodation within North Central London and is eligible for the treatment?
Patients residing in North Central London (Barnet, Camden, Enfield, Haringey and Islington), even if temporarily will still be assessed and considered for treatment based on the eligibility criteria.

What if someone is not eligible but would still like to be considered for treatment?
Such patients may wish to self-refer themselves into the PANORAMIC study led by Oxford University. More information can be found here